Take Solutions Ltd (NSE: TAKE, BSE: 532890) is a Chennai, Tamil Nadu-based company in the Healthcare Industry Software industry. With a market capitalisation of ₹188 Cr, it ranks #2,707 by market cap among the 6,197 Indian listed companies on FinBizNet, and #2 of 3 in Healthcare Industry Software. At ₹13.05 (as of 19 Nov 2026), the share price is 74.0% below its 52-week high of ₹50.14 and 32.1% above its 52-week low of ₹9.88. The share price is down 50.2% over one year and down 43.0% over three months.
| Current Price | ₹13.05 |
|---|---|
| Market Cap | ₹188 Cr |
| NSE Symbol | TAKE |
| BSE Code | 532890 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Technology |
| Sub-Industry | Health Care Technology > Healthcare Industry Software |
| P/E Ratio | 43.8 |
| Return on Equity | 16.53% |
| Return on Assets | -3.30% |
| 52-Week Range | ₹9.88 – ₹50.14 |
| 1-Year Price Change | -50.2% |
| 3-Month Price Change | -43.0% |
| Beta (1Y) | 0.78 |
| Dividend Yield | 0.00% |
| Headquarters | Chennai, Tamil Nadu |
| Website | www.takesolutions.com |
| Revenue | ₹29 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 7.5% |
| EPS (Basic) | ₹0.15 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Take Solutions Ltd reported revenue of ₹29 Cr in Q2 FY27, against ₹0 Cr in Q2 FY26 and down 3.1% from ₹30 Cr in Q1 FY27. It posted a net profit of ₹2 Cr for the quarter, against a net profit of ₹6 Cr in Q2 FY26 (down 64.9%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹0 Cr (Q3 FY26) to ₹54 Cr (Q4 FY26). The company reported a net loss in 1 of these 6 quarters.
| Quarter | Revenue | Net Profit | Net Margin |
|---|---|---|---|
| Q2 FY27 | ₹29 Cr | ₹2 Cr | 7.5% |
| Q1 FY27 | ₹30 Cr | ₹1 Cr | 3.5% |
| Q4 FY26 | ₹54 Cr | ₹4 Cr | 8.0% |
| Q3 FY26 | ₹0 Cr | ₹1 Cr | — |
| Q2 FY26 | ₹0 Cr | ₹6 Cr | — |
| Q1 FY26 | ₹0 Cr | −₹1 Cr | — |
Consolidated figures (₹ crore, XBRL filings).
Take Solutions Ltd reports no promoter group in its shareholding filing for Sept 2026. Delivery averaged 70.4% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services in life sciences and software and information technology in India. The company offers clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance and safety services backed by technology expertise. It also provides embed digital and employ mobile solutions for patient centricity insight in life science sector; and payer solutions, including access to billing insight through cloud adoption. In addition, the company offers payer-provider digital solution, which includes personalized medicine, wellness, and patient engagement; and medical device solution, such as technological transformation with chip level programming, DICOM devices, wearables, PROM, nano devices, and miOTs. TAKE Solutions Limited was incorporated in 2000 and is based in Chennai, India.
1. Life Sciences-This segment offers clinical data management, data standardization, and data interchange standards consortium services, as well as biostatistics and SAS programming services; and regulatory BPO services and technology solutions comprising submissions and report publishing, labeling and artwork, and regulatory strategy and information management services. 2. Segment Adjustment-0 3. Supply Chain Management-This segment offers enterprise mobility and WMS, supply chain collaboration, supplier onboarding/enablement, and Oracle advanced supply chain planning solutions. 4. Unallocated Corporate Income-0
1. Life Sciences and Support Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Inventurus Knowledge Solutions Limited | ₹28,485 Cr | 39.4 | 31.44% | ₹1,592 Cr | -2.1% |
| Take Solutions Ltd | ₹188 Cr | 43.8 | 16.53% | ₹29 Cr | -50.2% |
| Docmode Health Technologies Limited | ₹7 Cr | n/m | -1.69% | — | -81.1% |
Listed by market capitalisation. Ratios are shown for context only.
Take Solutions Ltd is trading at ₹13.05, with a market capitalisation of ₹188 Cr.
Take Solutions Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Technology space (Health Care Technology > Healthcare Industry Software).
Take Solutions Ltd has a P/E of 43.8 and a return on equity of 16.53%.
Take Solutions Ltd is listed on the NSE under the symbol TAKE and on the BSE under the scrip code 532890.
Take Solutions Ltd's share price is down 50.2% over one year and down 43.0% over three months. Its 52-week range is ₹9.88 to ₹50.14.
In Q2 FY27, Take Solutions Ltd reported revenue of ₹29 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.15 (consolidated, parsed from the company's exchange filing).
Take Solutions Ltd reported revenue of ₹29 Cr in Q2 FY27, against ₹0 Cr in Q2 FY26 and down 3.1% from ₹30 Cr in Q1 FY27.
Take Solutions Ltd reports no promoter group in its shareholding filing for Sept 2026.
Data as of 19 Nov 2026. Descriptive market data only — not investment advice.